Logo Lanfrica
  • Accueil
  • Atlas
  • Analyses
  • Documentation
  • Sign in

© 2026 Lanfrica. Tous droits réservés. Tous les droits d'auteur des ressources affichées sur le site Web Lanfrica appartiennent aux détenteurs de droits d'auteur d'origine, sauf indication contraire explicite.

Diagnostic performance of Transrectal ultrasound for Prostate volume estimation in Men with Benign Prostate Hyperplasia

Domaine:

healthcare
Créateur:
RotTajAbdChr
Éditeur:
WILEY
Hôte:
Background and Aim: Despite transrectal ultrasound (TRUS) being regarded as gold-standard for prostate volume estimation, concerns have been raised in literature concerning its accuracy especially in men with above-average prostate volumes. We aimed to evaluate the performance of TRUS for prostate volume estimation in a cohort of sub-Saharan African men since they are known to have relatively large mean prostate volumes. Methods: This was a prospective study of 77 sub-Saharan African men who had open simple prostatectomy for Benign Prostate Hyperplasia (BPH). Pre-operative TRUS determined total prostate volume (TPV) and transition zone volume (TZV). Following surgical enucleation, the adenoma was weighed (EPW) and its volume (EPV) also determined by fluid displacement. TRUS was repeated six weeks post-operatively to calculate the TRUS-estimated specimen volume (TESV). Results: The mean EPV, EPW, TRUS-estimated TZV, TRUS-estimated TPV and TESV were 79.1 ± 62.9mls, 79.1 ± 62.9g, 53.3 ± 28.5mls, 93.1 ± 48.9mls and 69.9 ± 44.6mls respectively. Pearson’s correlation showed perfect relationship between EPW and EPV with no difference in their mean values (r=1.000; P<0.001). Pearson’s correlation between TRUS-estimated TPV vs EPV, TRUS-estimated TZV vs EPV, and between TESV vs EPV were 0.932, 0.865 and 0.930 respectively (p = 0.0000). TRUS significantly under-estimated the TZV and TESV by 25.8ml and 9.2ml respectively; unrelated to severity of prostate enlargement. Conclusion: TRUS underestimates prostate volume, independent of prostate size. We propose simple formulae that could be used to improve the prostate volume determination from TRUS, especially if magnetic resonance imaging is not readily available or contraindicated.

Visit

doi.org

Licenses

https://creativecommons.org/licenses/by/4.0

Similaires

Benign prostatic hyperplasia and prostate carcinoma in native AfricansDiagnostic Performance of a Combined KLK2, miR-21, PSA, CRP, Albumin, AGR, and GGT Biomarker Panel for Distinguishing Prostate Cancer from Benign Prostatic Hyperplasia in Nigerian MenProstate-specific antigen, digital rectal examination, and prostate cancer detection: A study based on more than 7000 transrectal ultrasound-guided prostate biopsies in GhanaHigh-Resolution Melting PCR-Based SNP Germline Genotyping of KLK3, JAZF1, and HNF1B in Prostate Cancer and Benign Prostatic Hyperplasia in Nigerian Men—A Pilot StudyAssessment and Modeling of the Relationship Between Age, Prostate Volume, and Prostate‐Specific Antigen in a Population of Men From Sub‐Saharan Africa With a Low Risk of Prostate CancerGenetic risk of prostate cancer in Ugandan men

Benign prostatic hyperplasia and prostate carcinoma in native Africans

Objective To study the factors associated with morbidity and mortality in benig

Diagnostic Performance of a Combined KLK2, miR-21, PSA, CRP, Albumin, AGR, and GGT Biomarker Panel for Distinguishing Prostate Cancer from Benign Prostatic Hyperplasia in Nigerian Men

Abstract Background: Prostate-specific anti

Prostate-specific antigen, digital rectal examination, and prostate cancer detection: A study based on more than 7000 transrectal ultrasound-guided prostate biopsies in Ghana

High-Resolution Melting PCR-Based SNP Germline Genotyping of KLK3, JAZF1, and HNF1B in Prostate Cancer and Benign Prostatic Hyperplasia in Nigerian Men—A Pilot Study

Background/Objectives: Prostate cancer (PCa) and benign prostatic hyperplasia (BPH) are highly preva

Assessment and Modeling of the Relationship Between Age, Prostate Volume, and Prostate‐Specific Antigen in a Population of Men From Sub‐Saharan Africa With a Low Risk of Prostate Cancer

ABSTRACT PSA levels are influenced by several non‐tumor‐rel

Genetic risk of prostate cancer in Ugandan men

Background Men of African‐ancestry have elevated prostate cancer (PCa) incidence and mortality comp